Big news: Inductive has raised a $25M Series A to democratize AI that transforms small molecule drug discovery.
Our Compass platform, powered by our pre-competitive data consortium, predicts ADMET properties before synthesis - helping find higher quality drugs for patients,
We are proud to support @kyosu and the team at Inceptive. They are building AI models on the languages of biology and computer science, and using them to produce new mRNA therapies and vaccines.
In 2014, we founded Obvious with the simple idea that venture capital could be a force for positive change. Our next chapter will center on #GenerativeScience and the companies using AI to discover new technologies in climate, healthcare, and robotics.
